Lung microdialysis - A powerful tool for the determination of exogenous and endogenous compounds in the lower respiratory tract (mini-review)

AAPS Journal

Volumn 7, Issue 3, 2005, Pages

  Zeitlinger, Markus ^a   Müller, Markus ^a   Joukhadar, Christian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antibiotic; Lung; Microdialysis; Pharmacokinetic

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFACLOR; CEFPIROME; CEFPODOXIME; FROPENEM; GENTAMICIN; MEROPENEM; PIPERACILLIN; THEOPHYLLINE; TOBRAMYCIN;

AREA UNDER THE CURVE; DRUG BLOOD LEVEL; DRUG CLASSIFICATION; DRUG MECHANISM; DRUG METABOLISM; DRUG TISSUE LEVEL; ELECTIVE SURGERY; HUMAN; IN VIVO STUDY; INTERMETHOD COMPARISON; LOWER RESPIRATORY TRACT; LUNG LAVAGE; LUNG PARENCHYMA; MEASUREMENT; MECHANICAL PROBE; MEDICAL ETHICS; MEDICAL RESEARCH; MICRODIALYSIS; MUSCLE TISSUE; NONHUMAN; PATHOPHYSIOLOGY; PREDICTION; RESPIRATORY TRACT INFECTION; SHORT SURVEY; SIDE EFFECT; SKELETAL MUSCLE; SURGICAL TECHNIQUE; THORAX SURGERY; ANIMAL; DRUG EFFECT; EXTRACELLULAR FLUID; INSTRUMENTATION; LUNG; METABOLISM; METHODOLOGY; RESPIRATORY SYSTEM; REVIEW;

ANIMALS; ANTI-INFECTIVE AGENTS; EXTRACELLULAR FLUID; HUMANS; LUNG; MICRODIALYSIS; RESPIRATORY SYSTEM;

EID: 33644815680     PISSN: 15221059     EISSN: 15221059     Source Type: Journal    
DOI: 10.1208/aapsj070362     Document Type: Short Survey

References (74)

1. Muller M. Microdialysis in clinical drug delivery studies Adv Drug Deliv Rev. 2000;45:255-269. PubMed DOI:10.1016/S0169-409X(00)00113-7
2. de la Pena A, Liu P, Derendorf H. Microdialysis in peripheral tissues Adv Drug Deliv Rev. 2000;45:189-216.
3. Ungerstedt U. Microdialysis - principles and applications for the studies in animals and man J Intern Med. 1991;230:365-373. PubMed
4. Muller M, Haag O, Burgdorff T, et al. Characterization of peripheral-compartment kinetics of antibiotics by in vivo microdialysis in humans, Antimicrob Agents Chemother. 1996;40:2703-2709. PubMed
5. Joukhadar C, Derendorf H, Muller M. Microdialysis. A novel tool for clinical studies of anti-infective agents Eur J Clin Pharmacol.2001;57:211-219. PubMed DOI: 10.1007/S002280100301
6. Chalmers GW, Thomson L, Macleod KJ, et al. Endothelin-1 levels in induced sputum samples from asthmatic and normal subjects. Thorax. 1997,52:625-627.
7. Conte JE, Jr, Golden JA, Kipps J, McIver M, Zurlirden E. Intrapulmonary pharmacokinetics and pharmacodynamics of itraconazole and 14-hydroxyitraconazole at steady state.antimicrob Agents Chemother. 2004;48:3823-3827. PubMed DOI: 10.128/AAC.48.10.3823-3827.2004
8. Ingvast-Larsson C, Appelgren LE, Nyman G. Distribution studies of theophylline: microdialysis in rat and horse and whole body autoradiography in rat. J Vet Pharmacol Ther. 1992, 15:386-394. PubMed
9. Tomaselli F, Dittrich P, Maier A, et al. Penetration of piperacillin and tazobactam into pneumonic human lung tissue measured by in vivo microdialysis. Br J Clin Pharmacol. 2003;55:620-624. PubMed DOI: 10.1046/J.1365-2125.2003.01797.X
10. Herkner H, Muller MR, Kreischitz N, et al. Closed-chest microdialysis to measure antibiotic penetration into human lung tissue. Am J Respir Crit Care Med. 2002;165:273-276. PubMed
11. Tomaselli F, Maier A, Matzi V, Smolle-Juttner FM, Dittrich P. Penetration of meropenem into pneumonic human lung tissue as measured by in vivo microdialysis. Antimicrob Agents Chemother.2004;48:2228-2232. PubMed DOI: 10.1128/AAC.48.6.2228-2232.2004
12. Liu P, Muller M, Grant M, Webb Al, Obermann B Derendorf H. Interstitial tissue concentrations of cefpodoxime. J Antimicrob Chemother. 2002;50:19-22. PubMed DOI: 10.1093/JAC/DKF058
13. Grubb BR, Jones JH, Boucher RC, Mucociliary transport determined by in vivo microdialysis in the airways of normal and CIF mice. Am J Physiol Lung Cell Mol Physiol. 2004;286:L588-L595. PubMed DOI: 10.1152/AJPLUNG.00302.2003
14. Eichler W, Bechtel MJ, Klaus S, et al. Na/H+ exchange inhibitor cariporide: effects on respiratory dysfunction after cardiopulmonary bypass. Perfusion. 2004;19:33-40. DOI: 10.1191/0267659104PF712OA
15. Larsson CI. The use of an "internal standard" for control of the recovery in microdialysis. Life Sci. 1991:49:PL73-PL78. PubMed DOI: 10.1016/0024-3205(91)90082-M
16. De La Pena A, Dalla Costa T, Talton JD, et al. Penetration of cefaclor into the interstitial space fluid of skeletal muscle and lung tissue in rats. Pharm Res. 2001;18:1310-1314. PubMed DOI: 10.1023/A:1013042128791
17. Eisenberg EJ, Conzentino P, Eickhoff WM, Cundy KC. Pharmacokinetic measurement of drugs in lung epithelial lining fluid by microdialysis: aminoglycoside antibiotics in rat bronchi. J Pharmacol Toxicol Methods. 1993;29:93-98. PubMed DOI: 10.1016/1056-8719(93)90056-K
18. DeGuchi Y, Terasaki T, Yamada H, Tsuji A. An application of microdialysis to drug tissue distribution study: in vivo evidence for free-ligand hypothesis and tissue binding of beta-lactam antibiotics in interstitial fluids. J Pharmacobiodyn. 1992;15:79-89. PubMed
19. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. JAMA, 1995;274:639-644. PubMed DOI: 10.1001/JAMA.274.8.639
20. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med. 1995;333:1618-1624. PubMed DOI: 10.1056/NEJM199512143332408
21. Zeitlinger MA, Dehghanyar P, Mayer BX, et al. Relevance of soft-tissue penetration by levofloxacin for target site bacteria killing in patients with sepsis. Antimicrob Agents Chemother. 2003;47:3548-3553. PubMed DOI: 10.1128/AAC.47.11.3548-3553.2003
22. Joukhadar C, Frossard M, Mayer BX, et al. Impaired target site penetration of beta-lactams may account for therapeutic failure in patients with septic shock. Crit Care Med. 2001;29:385-391. PubMed DOI: 10.1097/00003246-200102000-00030
23. Lambert HP. Clinical significance of tissue penetration of antibiotics in the respiratory tract. Scand J Infect Dis Suppl. 1978;14:262-266. PubMed
24. Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men Clin Infect Dis. 1998;26:1-12. PubMed
25. Drusano GL, Craig WA. Relevance of pharmacokinetics and pharmacodynamics in selection of antibiotics for respiratory tract infections J Chemother. 1997;9:38-44. PubMed
26. Schentag JJ. Correlation of pharmacokinetic parameters to efficacy of antibiotics: relationships between serum concentrations, MIC values, and bacterial eradication in patients with gram-negative pneumonia. Scand J Infect Dis Suppl. 1990;74:218-234. PubMed
27. EMEA. Points to consider on pharmacokinetics and pharmacodynamics in the development of antibacterial medicinal products. Available at: http://www.emea.eu.int/pdfs/human/ewp/265599en.pdf. Accessed October 11, 2005.
28. FDA. Guidance for Industry. Developing antimicrobial drugs - general considerations for clinical trials. Available at: http//www.fda.gov/cder/guidance/2580dft.pdf. Accessed October 11, 2005.
29. Bergogne-Berezin E. New concepts in the pulmonary dispositon of antibotics Plum Pharmacol. 1995;8:65-81. PubMed DOI: 10.1006/PULP.1995.1009
30. Gail DB, Lenfant CJ. Cells of the lung: biology and clinical implications Am Rev Respir Dis. 1983;127:366-387. PubMed
31. Marlin GE, Burgess KR, Burgoyne J, Funnell GR, Guinness MD. Penetration of piperacillin into bronchial mucosa and sputum.Thorax. 1981;36:774-780. PubMed
32. Klastersky J, Thys JP, Mombelli G. Comparative studies of intermittent and continuous administration of aminoglycosides in the treatment of bronchopulmonary infections due to gram-negative bacteria Rev Infect Dis. 1981;3:74-83. PubMed
33. Brun Y, Forey F, Gamondes JP, Tebib A, Brune J, Fleurette J. Levels of erythromycin in pulmonary tissue and bronchial mucus compared to those of amoxycillin. J Antimicrob Chemother. 1981;8:459-466. PubMed
34. Jehl F, Muller-Serieys C, de Larminat V, Monteil H, Bergogne-Berezin E. Penetration of piperacillin-tazobactam into bronchial secretions after multiple doses to intensive care patients. Antimicrob Agents Chemother. 1994;38:2780-2784. PubMed
35. Bergogne-Berezin E, Muller-Serieys C, Aubier M, Dombret MC. Concentration of meropenem in serum and in bronchial secretions in patients undergoing fibreoptic bronchoscopy. Eur J Clin Pharmacol. 1994;46:87-88.Erratum in.Eur J Clin Pharmacol. 1994;46:282. PubMed
36. Cole DR, Pung J. Penetration of cefazolin into pleural fluid. Antimicrob Agents Chemother. 1977;11:1033-1035. PubMed
37. Byl B. Jacobs F, Roucloux I, de Franquen P, Capello M, Thys JP. Penetration of meropenem in lung, bronchial mucosa, and pleural tissues. Antimicrob Agents Chemother. 1999;43:681-682.
38. Reynolds HY. Use of bronchoalveolar lavage in humans - past necessity and future imperative Lung. 2000;178:271-293. PubMed DOI: 10.1007/S004080000032
39. Valcke Y, Pauwels R, Van der Straeten M, The penetration of aminoglycosides into the alveolar lining fluid of rats. The effect of airway inflammation. Am Rev Respir Dis. 1990;142:1099-1103. PubMed
40. Panteix G, Harf R, Desnottes JF, et al. Accumulation of pefloxacin in the lower respiratory tract demonstrated by bronchoalveolar lavage. J Antimicrob Chemother. 1994;33:979-985. PubMed
41. Allegranzi B, Cazzadori A, Di Perri G, et al. Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluid, J Antimicrob Chemother. 2000;46:319-322. PubMed DOI: 10.1093/JAC/46.2.319
42. Harf R, Panteix G, Desnottes JF, Diallo N, Leclercq M. Spiramycin uptake by alveolar macrophages. J Antimicrob Chemother. 1988;22:135-140. PubMed
43. Le Conte P, Potel G, Peltier P, et al. Lung distribution and pharmacokinetics of aerosolized tobramycin. Am Rev Respir Dis. 1993; 147:1279-1282. PubMed
44. Wollmer P, Pride NB, Rhodes CG, et al. Measurement of pulmonary erythromycin concentration in patients with lobar pneumonia by means of positron tomography. Lancet. 1982;320:1361-1364. PubMed DOI: 10.1016/S0140-6736(82)91269-7
45. Allegranzi B. Concentrations of single-dose meropenem (1 g iv) in bronchoalveolar lavage and epithelial lining fluid, J Antimicrob Chemother. 2000;46:319-322. PubMed DOI: 10.1093/JAC/46.2.319
46. Baldwin DR, Honeybourne D, Wise R. Pulmonary disposition of antimicrobial agents: in vivo observations and clinical relevance Antimicrob Agents Chemother. 1992;1176-1180. PubMed
47. Decre D, Bergogne-Berezin E. Pharmacokinetic of quinolones with special reference to the respiratory tree J Antimicrob Chemother. 1993;31:331-343. PubMed
48. Braude AC, Hornstein A, Klein M, Vas S, Rebuck AS. Pulmonary disposition of tobramycin. Am Rev Respir Dis. 1983;127:563-565. PubMed
49. Kunin CM. Clinical significance of protein binding of the penicillins Ann N Y Acad Sci. 1967;145:282-290. PubMed
50. Tulkens PM. Intracellular pharmacokinetics and localization of antibiotics as predictors of their efficacy against intraphagocytic infections. Scand J Infect Dis Suppl. 1990;74:209-217. PubMed
51. Boselli E, Breilh D, Cannesson M, et al. Steady-state plasma and intrapulmonary concentrations of piperacillin/tazobactam 4 g/0.5 g administered to critically ill patients with severe nosocomial pneumonia. Intensive Care Med. 2004;30:976-979. PubMed DOI: 10.1007/S00134-004-2222-8
52. Nix DE, Goodwin SD, Peloquin CA, Rotella DL, Schentag JJ. Antibiotic tissue penetration and its relevance: impact of tissue penetration on infection response Antimicrob Agents Chemother. 1991;35:1953-1959. PubMed
53. Zeitlinger M, Graninger W, Joukhadar C. Pharmacokinetics of the macrolides azithromycin, clarithromycin and roxithromycin in plasma and tissue - are there significant differences? Wien Klin Wochenschr vol. 11-12a. 2004:18-24.
54. Rodvold KA, Gotfried MH, Danziger LH, Servi Rj. Intrapulmonary steady-state concentrations of clarithromycin and azithromycin in healthy adult volunteers. Antimicrob Agents Chemother. 1997;41:1399-1402. PubMed
55. Poulin P, Theil FP, A priori prediction of tissue:plasma partition coefficients of drugs to facilitate the use of physiologically-based pharmacokinetic models in drug discovery. J Pharm Sci. 2000;89:16-35. PubMed DOI:10.1002/(SICI)1520-6017(200001)89:1<16::AID-JIS3>3.0.CD_2-E
56. Joukhadar C, Klein N, Mayer BX, et al. Plasma and tissue pharmacokinetics of cefpirome in patients with sepsis. Crit Care Med. 2002;30:1478-1482. PubMed DOI: 10.1097/00003246-200207000-00013
57. Joukhadar C, Stass H, Muller-Zellenberg U, et al. Penetration of moxifloxacin into healthy and inflamed subcutaneous adipose tissues in humans. Antimicrob Agents Chemother. 2003;47:3099-3103. PubMed DOI: 10.1128/AAC.47.10.3099-3103.2003
58. LeBel M. Fluoroquinolones in the treatment of cystic fibrosis: a critical appraisal Eur J Clin Microbiol Infect Dis. 1991;10:316-324. PubMed DOI: 10.1007/BF01967005
59. Mendelman PM, Smith AL, Levy J, Weber A, Ramsey B, Davis RL. Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis. 1985;132:761-765. PubMed
60. Barza M, Cuchural G. General principles of antibiotics tissue penetration. J Antimicro Chemother. 1985;15:59-75. PubMed
61. Muller-Serieys C, Bancal C, Dombret MC, et al. Penetration of cefpodoxime proxetil in lung parenchyma and epithelial lining fluid of noninfected patients. Antimicrob Agents Chemother. 1992;36:2099-2103. PubMed
62. Prokesch RC, Hand WL. Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother. 1982;21:373-380. PubMed
63. Forsgren A, Bellahsene A. Antibiotic accumulation in human polymorphonuclear leucocytes and lymphocytes. Scand J Infect Dis Suppl. 1985;44:16-23. PubMed
64. Peck CC, Nichols Al, Baker J, Lenert LL, Ezra D. Clinical Pharmacodynamics of theophylline. J Allergy Clin Immunol. 1985;76:292-297. PubMed DOI: 10.1016/0091-6749(85)90644-X
65. Devarajan PV, Sule PN, Parmar DV. Comparative pharmacodynamic-pharmacokinetic correlation of oral sustained-release theophylline formulation in adult asthmatics. Drug Dev Ind Pharm. 1999;25:529-534. PubMed DOI: 10.1081/DDC-100102204
66. Glynn-Barnhart A, Hill M, Szefler SJ. Sustained release theophylline preparations. Practical recommendations for prescribing and therapeutic drug monitoring Drugs. 1988;35:711-726. PubMed
67. Hook GE, Bend JR. Pulmonary metabolism of xenobiotics Life Sci. 1976;18:279-290. PubMed DOI: 10.1016/0024-3205(76)90056-4
68. Robertson CS, Gopinath SP, Uzura M, Valadka AB, Goodman JC. Metabolic changes in the brain during transient ischemia measured with microdialysis. Neurol Res. 1998;20:S91-S94. PubMed
69. Frykholm P, Hillered L, Langstrom B, et al. Increase of interstitial glycerol reflects the degree of ischaemic brain damage: a PET and microdialysis study in a middle celebral artery occlusion-reperfusion primate model. J Neurol Neurosurg Pychiatry. 2001;71:455-461. PubMed DOI: 10.1136/JNNP.71.4.455
70. Parkin M, Hopwood S, Jones DA, et al. Dynamic changes in brain glucose and lactate in pericontusional areas of the human cerebral cortex, monitored with rapid sampling on-line microdialysis: relationship with depolarisation-like events. J Cereb Blood Flow Metab. 2005;25:402-413. PubMed DOI: 10.1038/SJ.JCBFM.9600051
71. Taggart DP, el-Fiky M, Carter R, Bowman A, Wheatley DJ. Respiratory dysfunction after uncomplicated cardiopulmonary bypass. Ann Thorac Surg. 1993;56:1123-1128. PubMed DOI: 10.1016/0003-4975(95)90029-2
72. Theroux P, Chaitman BR, Danchin N, et al. Inhibition of the soduim-hydrogen exchanger with cariporide to prevent myocardial infarction in high-risk ischemic situations. Main results of the GUARDIAN trial. Guard during ischemia against necrosis (GUARDIAN) Investigators. Circulation. 2000;102:3032-3038. PubMed
73. Afzelius BA. A human syndrome caused by immotile cilia. Science. 1976;193:317-319. PubMed
74. Robinson M, Bye PT. Mucociliary clearance in cystic fibrosis Pediatr Pulmonol. 2002;33:293-306. PubMed DOI: 10.1002/PPUL.10079